Investors
List of the current and past investors into Neurotech Pharmaceuticals Inc with their respective financial instruments.Investor | Profile | Country | Phone | Round | |||
---|---|---|---|---|---|---|---|
![]() |
AGF Private Equity | France | +33 (1) 5818-5656 | N/A | |||
![]() |
Alpha Associates AG | Private equity fund of funds manager | Switzerland | +41 (43) 244-3100 | Series B | ||
![]() |
Apax Partners Inc | United States | Series B | ||||
![]() |
Atlas Venture LLP | Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. | United Kingdom | Series B | |||
![]() |
AVIDA Group | Germany | Series B | ||||
![]() |
Banexi Ventures Partners | France | +33 (1) 4014-2663 | N/A | |||
![]() |
Burrill & Co LLC | Diversified global financial services firm focused on the life sciences industry | United States | +1 (415) 591-5400 | Series B | ||
![]() |
CDC Capital Investissement | France | N/A | ||||
![]() |
Excalibur Fund Managers Ltd | United Kingdom | +44 (20) 7887-7642 | N/A | |||
![]() |
Fondinvest Capital | France | N/A | ||||
![]() |
GIMV NV (Gewestelijke Investeringsmaatschappij voor Vlaanderen) | Belgium | +32 (3) 290-2100 | N/A | |||
![]() |
Merlin Biosciences Ltd | United Kingdom | Series B | ||||
![]() |
Nexus Medical Partners | United States | +1 (561) 935-3966 | Series B | |||
![]() |
Omega Fund Management (US) Inc | United States | Series B | ||||
![]() |
Slater Technology Fund | United States | +1 (401) 831-6633 | N/A | |||
![]() |
Sofinnova Ventures Inc | United States | +1 (415) 228-3380 | N/A | |||
![]() |
SV Life Sciences Advisers Inc | United States | +1 (617) 367-8100 | Series B | |||
![]() |
Versant Ventures Management LLC | Venture capital firm focused on making investments in the healthcare and biotechnology industries. | United States | +1 (949) 729-4500 | Series B | ||
![]() |
XAnge Capital | France | N/A |